|Imaging biomarker roadmap for cancer studies|
JPB O'connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ...
Nature reviews Clinical oncology 14 (3), 169-186, 2017
|Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial|
D Athauda, K Maclagan, SS Skene, M Bajwa-Joseph, D Letchford, ...
The Lancet 390 (10103), 1664-1675, 2017
|Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga‐DOTATATE (DOTA‐DPhe1,Tyr3‐octreotate) and 18F‐FDG|
I Kayani, JB Bomanji, A Groves, G Conway, S Gacinovic, T Win, J Dickson, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2008
|Exenatide and the treatment of patients with Parkinson’s disease|
I Aviles-Olmos, J Dickson, Z Kefalopoulou, A Djamshidian, P Ell, ...
The Journal of clinical investigation 123 (6), 2730-2736, 2013
|Attenuation correction synthesis for hybrid PET-MR scanners: application to brain studies|
N Burgos, MJ Cardoso, K Thielemans, M Modat, S Pedemonte, J Dickson, ...
IEEE transactions on medical imaging 33 (12), 2332-2341, 2014
|Patients with adult‐onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs)|
SA Schneider, MJ Edwards, P Mir, C Cordivari, J Hooker, J Dickson, ...
Movement disorders: official journal of the Movement Disorder Society 22 (15 …, 2007
|Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson’s disease|
I Aviles-Olmos, J Dickson, Z Kefalopoulou, A Djamshidian, J Kahan, P Ell, ...
Journal of Parkinson's disease 4 (3), 337-344, 2014
|A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors|
I Kayani, BG Conry, AM Groves, T Win, J Dickson, M Caplin, JB Bomanji
Journal of Nuclear Medicine 50 (12), 1927-1932, 2009
|Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study|
P Schwingenschuh, D Ruge, MJ Edwards, C Terranova, P Katschnig, ...
Movement disorders 25 (5), 560-569, 2010
|European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods …|
A Varrone, JC Dickson, L Tossici-Bolt, T Sera, S Asenbaum, J Booij, ...
European journal of nuclear medicine and molecular imaging 40, 213-227, 2013
|Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an …|
CA Lane, J Barnes, JM Nicholas, CH Sudre, DM Cash, TD Parker, ...
The Lancet Neurology 18 (10), 942-952, 2019
|Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CT|
AM Groves, T Win, NJ Screaton, M Berovic, R Endozo, H Booth, I Kayani, ...
Journal of Nuclear Medicine 50 (4), 538-545, 2009
|Quantification of Myocardial Blood Flow in Absolute Terms Using 82Rb PET Imaging: The RUBY-10 Study|
SV Nesterov, E Deshayes, R Sciagrà, L Settimo, JM Declerck, XB Pan, ...
JACC: Cardiovascular Imaging 7 (11), 1119-1127, 2014
|Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancer|
I Kayani, N Avril, J Bomanji, S Chowdhury, A Rockall, A Sahdev, P Nathan, ...
Clinical Cancer Research 17 (18), 6021-6028, 2011
|EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0|
S Morbelli, G Esposito, J Arbizu, H Barthel, R Boellaard, NI Bohnen, ...
European Journal of Nuclear Medicine and Molecular Imaging 47, 1885-1912, 2020
|Diagnostic accuracy of 123I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies|
ND Papathanasiou, A Boutsiadis, J Dickson, JB Bomanji
Parkinsonism & related disorders 18 (3), 225-229, 2012
|The utility of 18F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery|
C Rathore, JC Dickson, R Teotónio, P Ell, JS Duncan
Epilepsy research 108 (8), 1306-1314, 2014
|Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study|
E Barkus, PD Morrison, D Vuletic, JC Dickson, PJ Ell, LS Pilowsky, ...
Journal of psychopharmacology 25 (11), 1462-1468, 2011
|Population-based blood screening for preclinical Alzheimer’s disease in a British birth cohort at age 70|
A Keshavan, J Pannee, TK Karikari, JL Rodriguez, NJ Ashton, ...
Brain 144 (2), 434-449, 2021
|A comparison of CT-and MR-based attenuation correction in neurological PET|
JC Dickson, C O’Meara, A Barnes
European journal of nuclear medicine and molecular imaging 41, 1176-1189, 2014